Holen Sie sich die Stockscreener-App
1.26
6.32%
-0.085
Handel nachbörslich:
1.26
Schlusskurs vom Vortag:
$1.345
Offen:
$1.33
24-Stunden-Volumen:
994.23K
Relative Volume:
4.07
Marktkapitalisierung:
$189.83M
Einnahmen:
$49.09M
Nettoeinkommen (Verlust:
$-52.15M
KGV:
-1.1455
EPS:
-1.1
Netto-Cashflow:
$-45.93M
1W Leistung:
-10.64%
1M Leistung:
-21.74%
6M Leistung:
-20.00%
1J Leistung:
-11.89%
1-Tages-Spanne:
$1.26
$1.33
1-Wochen-Bereich:
$1.26
$1.45
52-Wochen-Spanne:
$1.15
$2.21
Biodesix Inc Stock (BDSX) Company Profile
Firmenname
Biodesix Inc
Sektor
Branche
Telefon
303-417-0500
Adresse
919 WEST DILLON ROAD, LOUISVILLE
Vergleichen Sie BDSX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| BDSX | 1.26 | 189.83M | 49.09M | -52.15M | -45.93M | -1.10 |
| TMO | 501.29 | 192.46B | 42.37B | 6.14B | 7.78B | 15.26 |
| DHR | 230.06 | 166.23B | 23.74B | 3.89B | 4.98B | 7.93 |
| A | 126.92 | 36.47B | 6.50B | 1.41B | 1.42B | 3.82 |
| IQV | 191.04 | 34.67B | 15.32B | 1.41B | 1.96B | 5.95 |
| IDXX | 419.83 | 34.38B | 3.84B | 866.24M | 792.60M | 9.80 |
Biodesix Inc Stock (BDSX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-11-17 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-23 | Eingeleitet | BTIG Research | Buy |
| 2020-11-23 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-11-23 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-11-23 | Eingeleitet | William Blair | Outperform |
Biodesix Inc Aktie (BDSX) Neueste Nachrichten
Biodesix chief commercial officer sells shares worth $644 - Investing.com India
Biodesix CEO Scott Hutton sells $5,219 in stock - Investing.com India
Biodesix CEO Scott Hutton sells $5,219 in stock By Investing.com - Investing.com Australia
Biodesix's chief development officer sells shares for $595 - Investing.com
Biodesix CFO Robin Harper Cowie sells $1,355 in stock - Investing.com
Biodesix chief commercial officer sells shares worth $644 By Investing.com - Investing.com UK
Biodesix's chief development officer sells shares for $595 By Investing.com - Investing.com UK
Biodesix chief accounting officer sells $283 in stock - Investing.com
Biodesix, Inc. (NASDAQ:BDSX) Q3 2024 Earnings Call Transcript - MSN
Insider Buys Additional US$137k In Biodesix Stock - Simply Wall St
Biodesix chairman John Patience acquires $103,710 in stock - Investing.com India
Biodesix chairman John Patience acquires $103,710 in stock By Investing.com - Investing.com Australia
Biodesix director Jack Schuler buys $136k in stock - Investing.com
Biodesix director Kennedy Lawrence T. Jr. acquires $97,068 in stock - Investing.com
Biodesix director Matthew Strobeck acquires $55,915 in stock - Investing.com
Biodesix director Massarany buys $30,865 in common stock - Investing.com India
Biodesix director Kennedy Lawrence T. Jr. acquires $97,068 in stock By Investing.com - Investing.com Nigeria
Biodesix director Massarany buys $30,865 in common stock By Investing.com - Investing.com UK
Earnings call: Biodesix sees strong growth in Q3 with $18.2M revenue - Investing.com India
Brokerages Set Biodesix, Inc. (NASDAQ:BDSX) PT at $3.06 - MarketBeat
Biodesix, Inc. (NASDAQ:BDSX) Receives Consensus Rating of “Buy” from Analysts - Defense World
Biodesix (NASDAQ:BDSX) Releases Quarterly Earnings Results, Meets Expectations - MarketBeat
Biodesix reports Q3 EPS (7c), consensus (7c) - MSN
Biodesix Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Biodesix Inc (BDSX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Operational ... - Yahoo Finance UK
Biodesix Inc (BDSX) Q3 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com
Biodesix Reports Strong Q3 2024 Growth in Diagnostics - TipRanks
Biodesix trims losses but misses Wall Street sales projection - BizWest
Biodesix Announces Third Quarter 2024 Results and Highlights - GlobeNewswire
Biodesix, Inc. (BDSX) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Biodesix Inc (BDSX) Q3 2024 Earnings: Revenue at $18.2M, EPS Mat - GuruFocus.com
Biodesix, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Biodesix, Inc. Reiterates Revenue Guidance for the Fiscal Year 2024-25 - Marketscreener.com
What To Expect From Biodesix Inc (BDSX) Q3 2024 Earnings - Yahoo Finance
With 47% ownership, Biodesix, Inc. (NASDAQ:BDSX) insiders have a lot riding on the company's future - Yahoo Finance
Biodesix to Participate in Three Investor Conferences in November - The Manila Times
Scotiabank Initiates Coverage of Biodesix (BDSX) with Sector Outperform Recommendation - MSN
Biodesix (BDSX) Set to Announce Quarterly Earnings on Friday - Defense World
Biodesix (BDSX) Scheduled to Post Earnings on Friday - MarketBeat
Biodesix to Report Third Quarter 2024 Financial Results on November 1, 2024 - Business Wire
Short Interest in Biodesix, Inc. (NASDAQ:BDSX) Rises By 29.3% - MarketBeat
Biodesix, Inc. (NASDAQ:BDSX) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
Biodesix Announces New Data Presentation at CHEST 2024 Annual Meeting and the Launch of a Complementary Clinical Study - BioSpace
Perceptive Advisors LLC Takes $3.33 Million Position in Biodesix, Inc. (NASDAQ:BDSX) - Defense World
2,173,880 Shares in Biodesix, Inc. (NASDAQ:BDSX) Bought by Perceptive Advisors LLC - MarketBeat
Biodesix, Inc. (NASDAQ:BDSX) Short Interest Down 9.2% in September - MarketBeat
CVI Holdings LLC Makes New Investment in Biodesix, Inc. (NASDAQ:BDSX) - Defense World
Finanzdaten der Biodesix Inc-Aktie (BDSX)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.04%
3.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):